An analysis based on over 700 lung transcriptome samples from severe COVID‐19 patients that present comorbidities revealed that ACE2 is highly expressed in the lungs compared to control individuals (Pinto et al., 2020), suggesting that ACE2 expression level correlates with the severity of COVID‐19. This evidence concerns the gene ACE2 and COVID-19.